ClinicalTrialsFinder
RecruitingNCT07678177

An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients

A Multi-center, Prospective, Observational Study to Evaluate the Safety and Efficacy of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients

Sponsor

HK inno.N Corporation

Enrollment

5,384 participants

Start Date

Mar 7, 2023

Study Type

OBSERVATIONAL

Conditions

GERD (Gastroesophageal Reflux Disease)

Summary

This study aims to evaluate the status of AE and improvement effect of K-CAB Tab/K-CAB ODT(Tegoprazan) 50mg in patients with GERD.

Eligibility

Min Age: 19 Years

Inclusion Criteria3

  • Subjects over 19 years of age as of the date of consent
  • Subjects with a total score of 8 or more in the Korean Gastroesophageal Reflux Disease Questionnaire (GerdQ) based on Visit 1
  • Subjects who voluntarily decides to participate and agrees in writing to the consent form of the study

Exclusion Criteria3

  • Subjects who have hypersensitivity reactions and a medical history of Benzimidazole or components of the investigational drug
  • Subjects on Atazanavir, Nelfinavir, or Rilpivirine-containing medications
  • Pregnant and lactating women

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

HK inno.N

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07678177

Related Trials

New Topical tReatment Options for Symptomatic patiEnts With Nonerosive gastroesophageaL Reflux dIsease (The RELIEF Trial)

NCT076243831 location

QUality of Sleep Improvement With Evening Topical Therapy for Non-Erosive Gastroesophageal Reflux Disease (The QUIET Trial)

NCT077003422 locations

Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disease (GERD) Symptoms

NCT066134385 locations

Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare

NCT071255211 location

A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)

NCT0703787575 locations